Lv7
4940 积分 2022-09-28 加入
Navigating the Evolving Landscape of EGFR -Mutated NSCLC
1天前
已完结
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
4天前
已完结
A renaissance in targeting the PI3K/AKT/mTOR pathway
4天前
已完结
One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma
6天前
已完结
Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial
15天前
已完结
A review of current therapeutics for psoriasis: Systemic and topical use of non-biological drugs
20天前
已完结
2025 FDA approvals
3个月前
已完结
Pharmacological targeting of the JAK–STAT pathway: new concepts and emerging indications
3个月前
已完结
Advances in the treatment of systemic lupus erythematosus
3个月前
已完结
Deaths potentially averted by small changes in physical activity and sedentary time: an individual participant data meta-analysis of prospective cohort studies
3个月前
已完结
皖公网安备34019202002308
